Of all the advances in treating lung cancer, the field of personalized medicine is one of the most promising – and vital.  That’s because it helps doctors determine what – if any – “driver mutations” cancer cells may contain. These are alterations in the genetic material that impact cell growth and survival.  Mutations are found in more than 45 percent of patients diagnosed with lung cancer, which is why knowing about them makes all the